Can diet, probiotics, and supplements actually boost GLP-1?
Quick answer
GLP-1 is an incretin hormone secreted by intestinal L-cells that stimulates insulin secretion, slows gastric emptying, and reduces appetite. Pharmacological GLP-1 receptor agonists like semaglutide achieve sustained supraphysiological receptor activation that dietary and probiotic interventions cannot replicate based on current evidence. The claim that a probiotic-botanical blend increases endogenous GLP-1 by 300% has not been independently validated in peer-reviewed literature.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @doctorsood actually say?
@doctorsood claims that "your gut microbiome produces GLP-1" and that natural strategies like diet, sleep, and probiotics can boost your body's own GLP-1 production "without any potential side effects." The video then pivots to a paid partnership with Resbiotic, stating that "in clinical studies, this formula was shown to significantly increase natural GLP-1 levels by 300% compared to control." That 300% figure is the one doing the heavy lifting here, and it deserves serious scrutiny.
The creator also names specific ingredients: L. plantarum (a probiotic strain), white mulberry, fenugreek, and chromium, calling them "known to support metabolic health." She wraps with genuinely reasonable lifestyle advice about fiber, protein, resistance training, and sleep. Those parts are fine. The supplement pitch is where things get complicated.
Does the science back this up?
The foundational biology is real. L-cells in the gut do secrete GLP-1 in response to food intake and microbial signals, and some probiotic interventions have shown modest effects on GLP-1 secretion. But "300% increase" is an extraordinary claim that requires extraordinary evidence, and the public research base does not clearly support it.
A 2019 meta-analysis by Zhao et al. in Nutrients found that probiotic supplementation produced statistically significant but modest improvements in GLP-1 levels across several trials, nowhere near three-fold increases. L. plantarum specifically has been studied in metabolic contexts. A 2020 randomized controlled trial by Barreto et al. in Frontiers in Nutrition found L. plantarum CECT 7527/7528/7529 improved lipid profiles but GLP-1 data were secondary and limited. Fenugreek and chromium have some supporting evidence for blood sugar modulation, but their GLP-1 effects in humans are not well-characterized. White mulberry's GLP-1 data in humans is largely absent from peer-reviewed literature.
What did they get wrong (or right)?
Credit where it is due: the basic physiology is accurate. The gut microbiome does influence GLP-1 secretion. High-fiber foods, protein, resistance training, and adequate sleep genuinely support metabolic health, and those recommendations align with mainstream evidence.
What's wrong: the "300% increase" claim almost certainly comes from Resbiotic's own internal or commissioned research, not independent peer-reviewed clinical trials. That distinction matters enormously. Sponsored product research frequently uses small samples, short durations, or surrogate endpoints that do not hold up under independent replication. The creator says "there is research to support this" without citing a specific study, journal, or sample size. That vagueness is a red flag, not a reassurance.
Also wrong: the claim that natural GLP-1 boosting works "without any potential side effects" is an oversimplification. Fenugreek can interact with anticoagulants and diabetes medications. Chromium in high doses has documented safety concerns. Blanket "no side effects" language for any bioactive supplement is not accurate.
What should you actually know?
If you are considering a GLP-1 medication for weight management or type 2 diabetes, no supplement currently on the market replicates the clinical outcomes seen with semaglutide or tirzepatide in large-scale trials. The SUSTAIN and SURMOUNT trial programs involved tens of thousands of patients. No probiotic or botanical supplement has anything close to that evidence base for meaningful weight loss or glycemic control.
That does not mean lifestyle interventions are worthless. They are not. Dietary fiber genuinely stimulates GLP-1 release from L-cells, and this is supported by mechanistic and clinical research (Tolhurst et al., 2012, Cell Metabolism). Resistance training improves insulin sensitivity through multiple pathways. These are real effects. They just do not justify a 300% GLP-1 marketing claim for a specific supplement blend.
If you see any health creator promoting a supplement with a specific percentage improvement claim tied to a paid partnership, ask for the study: who funded it, what was the sample size, was it peer-reviewed, and has it been replicated independently? If they cannot answer those questions, that is your answer.
Is there a conflict of interest here?
Yes, and the creator discloses it, which is the right move. She explicitly says "I have a partner" and shares a discount code. That transparency is appropriate under FTC guidelines. However, disclosed conflicts of interest still affect how you should weigh the claims. A creator receiving compensation to recommend a product has an incentive to present that product's research in the most favorable light possible. The 300% figure appears to originate from the brand's own materials, not from an independent research team with no financial stake in the outcome.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Can diet, probiotics, and supplements actually boost GLP-1?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Can diet, probiotics, and supplements actually boost GLP-1? should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
GLP-1 is an incretin hormone secreted by intestinal L-cells that stimulates insulin secretion, slows gastric emptying, and reduces appetite.
FormBlends verdict
GLP-1 is an incretin hormone secreted by intestinal L-cells that stimulates insulin secretion, slows gastric emptying, and reduces appetite. Pharmacological GLP-1 receptor agonists like semaglutide achieve sustained supraphysiological receptor activation that dietary and probiotic interventions cannot replicate based on current evidence. The claim that a probiotic-botanical blend increases endogenous GLP-1 by 300% has not been independently validated in peer-reviewed literature.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GLP-1 is an incretin hormone secreted by intestinal L-cells that stimulates insulin secretion, slows gastric emptying, and reduces appetite. Pharmacological GLP-1 receptor agonists like semaglutide achieve sustained supraphysiological receptor activation that dietary and probiotic interventions cannot replicate based on current evidence. The claim that a probiotic-botanical blend increases endogenous GLP-1 by 300% has not been independently validated in peer-reviewed literature.
- GLP-1 is a real gut hormone, and diet, fiber, and exercise do influence its secretion. This part of the video is grounded in legitimate physiology.
- The 300% GLP-1 increase claim for Resbiotic has no independently peer-reviewed backing identifiable in public literature. Treat brand-sponsored outcome figures with skepticism.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- GLP-1 is a real gut hormone, and diet, fiber, and exercise do influence its secretion. This part of the video is grounded in legitimate physiology.
- The 300% GLP-1 increase claim for Resbiotic has no independently peer-reviewed backing identifiable in public literature. Treat brand-sponsored outcome figures with skepticism.
- A 2019 meta-analysis (Zhao et al., Nutrients) found probiotics produced statistically significant but modest GLP-1 changes, not three-fold increases.
- Fenugreek and chromium are bioactive compounds with known drug interactions. No supplement stack is side-effect-free by default.
- Pharmacological GLP-1 receptor agonists like semaglutide have been tested in trials involving tens of thousands of patients. No probiotic supplement has a comparable evidence base for weight loss outcomes.
- FTC rules require disclosure of paid partnerships. The creator disclosed hers, but a disclosed conflict of interest still means you should independently verify specific numerical claims before acting on them.
- Dietary fiber intake remains one of the best-supported natural strategies for enhancing GLP-1 secretion, per mechanistic research from Tolhurst et al. (2012, Cell Metabolism).
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
DoctorSood, M.D. · TikTok creator
160.9K views on this video
There are natural ways to increase GLP-1 such as through diet, exercise, and probiotics. If you are interested in a supplement option, check out resM by Resbiotic. This is a great option because it has research backed ingredients, is third party tested, and doesn’t have fillers or additives. Discuss with your Doctor if this is a good option for you. I have partnered to get you guys a discount if you use code “drsood20”. 🫡 #medical #health #metabolichealth #glp1 #resbiotic
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by DoctorSood, M.D., not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.